{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T15:57:07Z","timestamp":1791388627065,"version":"4.3.3"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12957-016-0926-1","type":"journal-article","created":{"date-parts":[[2016,6,29]],"date-time":"2016-06-29T12:58:22Z","timestamp":1467205102000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Pneumatosis intestinalis after gefitinib therapy for pulmonary adenocarcinoma: a case report"],"prefix":"10.1186","volume":"14","author":[{"given":"Ai","family":"Maeda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masao","family":"Nakata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuhiko","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuro","family":"Yukawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinsuke","family":"Saisho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riki","family":"Okita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,6,29]]},"reference":[{"key":"926_CR1","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1259\/bjr\/19815818","volume":"85","author":"E Thornton","year":"2012","unstructured":"Thornton E, Howard SA, Jagannathan J, Krajewski KM, Shinagare AB, O\u2019Regan K, et al. Imaging features of bowel toxicities in the setting of molecular targeted therapies in cancer patients. Br J Radiol. 2012;85:1420\u20136.","journal-title":"Br J Radiol"},{"key":"926_CR2","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1093\/jnci\/djk011","volume":"99","author":"O Mir","year":"2007","unstructured":"Mir O, Mouthon L, Alexandre J, et al. Bevacizumab-induced cardiovascular events: a consequence of cholesterol emboli syndrome? J Natl Cancer Inst. 2007;99:85\u20136.","journal-title":"J Natl Cancer Inst"},{"key":"926_CR3","doi-asserted-by":"crossref","first-page":"240","DOI":"10.15403\/jgld.2014.1121.233.pje","volume":"23","author":"PJ Edmonds","year":"2014","unstructured":"Edmonds PJ, Thongprayoon C, Thamcharoen N, Cheungpasitporn W. Pneumatosis intestinalis from thromboembolism: a fatal complication in a patient with total artificial heart. J Gastrointestin Liver Dis. 2014;23:240.","journal-title":"J Gastrointestin Liver Dis"},{"key":"926_CR4","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.2214\/AJR.12.8782","volume":"199","author":"AB Shinagare","year":"2012","unstructured":"Shinagare AB, Howard SA, Krajewski KM, Zukotynski KA, Jagannathan JP, Ramaiya NH. Pneumatosis intestinalis and bowel perforation associated with molecular targeted therapy: an emerging problem and the role of radiologists in its management. AJR Am J Roentgenol. 2012;199:1259\u201365.","journal-title":"AJR Am J Roentgenol"},{"key":"926_CR5","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1007\/s10637-010-9458-7","volume":"29","author":"R Coriat","year":"2011","unstructured":"Coriat R, Ropert S, Mir O, Billemont B, Chaussade S, Massault PP, et al. Pneumatosis intestinalis associated with treatment of cancer patients with the vascular growth factor receptor tyrosine kinase inhibitors sorafenib and sunitinib. Invest New Drugs. 2011;29:1090\u20133.","journal-title":"Invest New Drugs"},{"key":"926_CR6","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s10456-010-9197-6","volume":"14","author":"M Walraven","year":"2011","unstructured":"Walraven M, Witteveen PO, Lolkema MP, van Hillegersberg R, Voest EE, Verheul HM. Antiangiogenic tyrosine kinase inhibition related gastrointestinal perforations: a case report and literature review. Angiogenesis. 2011;14:135\u201341.","journal-title":"Angiogenesis"},{"key":"926_CR7","doi-asserted-by":"crossref","first-page":"297","DOI":"10.3816\/CCC.2010.n.043","volume":"9","author":"WA Messersmith","year":"2010","unstructured":"Messersmith WA, Jimeno A, Jacene H, Zhao M, Kulesza P, Laheru DA, et al. Phase I trial of oxaliplatin, infusional 5-fluorouracil, and leucovorin (FOLFOX4) with erlotinib and bevacizumab in colorectal cancer. Clin Colorectal Cancer. 2010;9:297\u2013304.","journal-title":"Clin Colorectal Cancer"},{"key":"926_CR8","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/JTO.0b013e3182381564","volume":"7","author":"M Iwasaku","year":"2012","unstructured":"Iwasaku M, Yoshioka H, Korogi Y, Kunimasa K, Nishiyama A, Nagai H, et al. Pneumatosis cystoides intestinalis after gefitinib therapy for pulmonary adenocarcinoma. J Thorac Oncol. 2012;7:257.","journal-title":"J Thorac Oncol"},{"key":"926_CR9","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/1471-2407-12-87","volume":"12","author":"JY Lee","year":"2012","unstructured":"Lee JY, Han HS, Lim SN, Shim YK, Choi YH, Lee OJ, et al. Pneumatosis intestinalis and portal venous gas secondary to gefitinib therapy for lung adenocarcinoma. BMC Cancer. 2012;12:87.","journal-title":"BMC Cancer"},{"key":"926_CR10","doi-asserted-by":"crossref","first-page":"987410","DOI":"10.1155\/2012\/987410","volume":"2012","author":"F Ejtehadi","year":"2012","unstructured":"Ejtehadi F, Chatzizacharias NA, Kennedy H. Pneumatosis intestinalis as the initial presentation of systemic sclerosis: a case report and review of the literature. Case Rep Med. 2012;2012:987410.","journal-title":"Case Rep Med"},{"key":"926_CR11","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1093\/ajcp\/48.5.455","volume":"48","author":"BH Smith","year":"1967","unstructured":"Smith BH, Welter LH. Pneumatosis intestinalis. Am J Clin Pathol. 1967;48:455\u201365.","journal-title":"Am J Clin Pathol"},{"key":"926_CR12","first-page":"1666","volume":"16","author":"RR Hall","year":"1984","unstructured":"Hall RR, Anagnostou A, Kanojia M, Zander A. Pneumatosis intestinalis associated with graft-versus-host disease of the intestinal tract. Transplant Proc. 1984;16:1666\u20138.","journal-title":"Transplant Proc"},{"key":"926_CR13","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1056\/NEJMoa0909530","volume":"24","author":"M Maemondo","year":"2010","unstructured":"Maemondo M, Inoue A, Kobayashi K, Sugawara S, Oizumi S, Isobe H, et al. Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR. N Engl J Med. 2010;24:2380\u20138.","journal-title":"N Engl J Med"},{"key":"926_CR14","doi-asserted-by":"publisher","first-page":"719713","DOI":"10.1155\/2012\/719713","volume":"2012","author":"H Zhang","year":"2012","unstructured":"Zhang H, Jun SL, Brennan TV. Pneumatosis intestinalis: not always a surgical indication. Case Rep Surg. 2012;2012:719713. doi: 10.1155\/2012\/719713 .","journal-title":"Case Rep Surg"},{"key":"926_CR15","doi-asserted-by":"crossref","first-page":"6452","DOI":"10.4076\/1757-1626-2-6452","volume":"12","author":"E Schr\u00f6pfer","year":"2009","unstructured":"Schr\u00f6pfer E, Meyer T, Cases J. Surgical aspects of pneumatosis cystoides intestinalis: two case reports. Cases J. 2009;12:6452.","journal-title":"Cases J"},{"key":"926_CR16","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1007\/s11605-007-0241-9","volume":"11","author":"AJ Greenstein","year":"2007","unstructured":"Greenstein AJ, Nguyen SQ, Berlin A, Corona J, Lee J, Wong E, et al. Pneumatosis intestinalis in adults: management, surgical indications, and risk factors for mortality. J Gastrointest Surg. 2007;11:1268\u201374.","journal-title":"J Gastrointest Surg"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-016-0926-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,23]],"date-time":"2020-09-23T03:15:02Z","timestamp":1600830902000},"score":1,"resource":{"primary":{"URL":"http:\/\/wjso.biomedcentral.com\/articles\/10.1186\/s12957-016-0926-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,29]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["926"],"URL":"https:\/\/doi.org\/10.1186\/s12957-016-0926-1","relation":{},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,29]]},"article-number":"175"}}